News/ News/ Sales and Marketing/ Top stories Antitrust delay scuppers Novartis’ $1bn generics sale to Aurobindo Phil Taylor Aurobindo, generic, Mergers and acquisitions, Novartis 0 Comment Novartis has called off the sale of two US generics businesses to India’s Aurobindo Pharma, part of a Share X Antitrust delay scuppers Novartis’ $1bn generics sale to Aurobindo https://pharmaphorum.com/news/antitrust-delay-scuppers-novartis-1bn-generics-sale-to-aurobindo/
News Sanofi to combat shortages with European medicines ingredient firm Richard Staines api, Aurobindo, Cipla, coronavirus, Dr Reddy's, drug shortages, Sanofi 0 Comment Sanofi is to create a European company focused on production and marketing of active pharmaceutical ingredients (API) – Share X Sanofi to combat shortages with European medicines ingredient firm https://pharmaphorum.com/news/sanofi-to-combat-shortages-with-european-medicines-ingredient-firm/
Aurobindo, generic, Mergers and acquisitions, Novartis
0 Comment
